Aceto Corporation (NASDAQ:ACET) Files An 8-K Other Events
On August 1, 2019, Aceto Corporation filed a Monthly Operating Report for the period from May 1, 2019 to May 31, 2019 (the “Report”) with the United States Bankruptcy Court for the District of New Jersey. The Report is attached as Exhibit 99.1 hereto and is incorporated herein by reference.
|99.1||May 2019 Monthly Operating Report of Aceto Corporation.|
ACETO CORP Exhibit
EX-99.1 2 tv526850_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Case 19-13448-VFP Doc 787 Filed 08/01/19 Entered 08/01/19 15:51:19 Desc Main Document Page 1 of 11 UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF NEW JERSEY In re: Aceto Corporation,…
To view the full exhibit click
About Aceto Corporation (NASDAQ:ACET)
Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products.